N. Mitro, University of Milan

Condividi su
Data dell'evento: 27/02/2015
milano_torino_2

Friday, February 27th 2015  h. 14,00
Seminars Room, NICO

Linking fatty acid metabolism to peripheral neuropathy
Nico Mitro
Department of Pharmacological and Biomolecular Sciences, University of Milan
Myelin is a membrane characterized by high lipid content to facilitate impulse propagation. Changes in myelin fatty acid (FA) composition have been associated with peripheral neuropathy, but the specific role of peripheral nerve FA synthesis in myelin formation and function is poorly understood.
We have found that mice lacking sterol regulatory element-binding factor-1c (Srebf1c) have blunted peripheral nerve FA synthesis that results in development of peripheral neuropathy. Srebf1c null mice develop Remak bundle alterations and hypermyelination of small caliber fibers that impair nerve function.
Peripheral nerves lacking Srebf1c show decreased FA synthesis and glycolytic flux, but increased FA catabolism and mitochondrial function. These metabolic alterations are the result of local accumulation of two endogenous peroxisome proliferator-activated receptor-α (Pparα) ligands, 1-palmitoyl-2-oleyl-sn-glycerol-3-phosphatidylcholine and 1-stearoyl-2-oleyl-sn-glycerol-3-phosphatidylcholine. Treatment with a Pparα antagonist rescues the neuropathy of Srebf1c null mice. These findings reveal the importance of peripheral nerve FA synthesis to sustain myelin structure and function.

Host: Alessandro Vercelli

download pdf

Ricerca

Interferenti endocrini. Il Parlamento europeo impegna la Commissione a emanare norme più restrittive

Buone notizie da Bruxelles. Il Parlamento europeo ha approvato a larga maggioranza una risoluzione che impegna la Commissione (vecchia e nuova) a emanare entro giugno 2020 una normativa più restrittiva che disciplini cosmetici, giocattoli e imballaggi alimentari e che - finalmente - applichi agli EDCs le stesse cautele usate per i composti classificati come sospetti cangerogeni. Una tesi a lungo sostenuta dalla Endrocrine Society e fortemente osteggiata dai rappresentanti della industria chimica.

30 aprile 2019